Wednesday, November 18th, 2015 at 10:25 am
While there are many cases of colon polyps that do not pose a serious threat to sufferers, patients who develop polyp clumps in their colons may deal with symptoms that can lead to colon cancer if not treated properly. Bearing this in mind, it is important to be aware of some of the common symptoms linked to colon polyps:
- Bleeding in the rectum
- Recurring bowel problems
- Stools that appear dark in color or contain red streaks
- Vomiting and nausea caused by abdominal pain
- Anemia caused by recurring bleeding in the colon
- Unusual exhaustion and breathing problems
Older individuals who are diagnosed with colon polyps are advised to seek medical attention if they experience the above symptoms, especially if there is a family history of colon cancer.
Unfortunately, patients who are prescribed Xarelto for stroke or blood clots are at risk of developing severe colon polyps that can be fatal in severe cases. If you have been affected by this dangerous drug, the lawyers of Williams Kherkher are prepared to work on your behalf towards claiming compensation from the negligent pharmaceutical companies whose product caused you harm. Call (800) 220-9341 to discuss your case with our legal team today.
Monday, November 16th, 2015 at 10:57 am
Seventy-nine-year-old farmer Patrick Walsh, who had sued DePuy International Ltd. of Leeds, England and claimed that he had been given a defective hip implant that the company had manufactured, has recently settled with the company for an undisclosed sum.
Two other separate cases against DePuy International in connection with the alleged defective hip replacement devices were scheduled for hearings during the second week of November and a later date in December have also been settled out of court, Justice Kevin Cross said.
Judge Cross congratulated both parties for taking the “sensible approach” and settling out of court. Cross earlier encouraged the parties involved in legal actions concerning the alleged defective DePuy hip implants to come up with “innovative ways” to resolve their cases rather than add to the already clogged up High Court lists.
We at Williams Kherkher are proud of our moral and legal commitment to our clients. We encourage you to make us a part of your legal arsenal should you have the misfortune of being affected by defective hip implants manufactured by DePuy. Call our offices today at (800) 220-9341 to discuss your case with our legal team.
Friday, November 13th, 2015 at 11:23 am
David Geffen of the School of Medicine at the University of California, along with associate clinical professor of medicine Victor Gura and his colleagues have initiated the development of a wearable artificial kidney (WAK), which aims to filter the blood of chronic kidney disease patients continuously instead of just twice or thrice a week.
The device has undergone a trial involving seven patients with end-stage kidney disease who were required to wear the device for 24 hours in Seattle.
Gura said at the annual meeting of the American Society of Nephrology at Kidney Week on Saturday, November 7 that findings of the trial showed that the WAK was able to remove water and salts from the blood of the kidney disease patients in the same manner that healthy kidneys would function; he added that on top of this marvel, the patients involved in the trial did not feel any side effects or discomfort during the test.
Our experienced attorneys at Williams Kherkher have a great deal of legal knowledge and an ample supply of resources to ensure that we provide the best legal representation for our clients. If you have experienced negative side effects from the use of the kidney dialysate GranuFlo, contact our attorneys by calling our office today at (800) 220-9341.
Thursday, November 12th, 2015 at 5:18 pm
Earlier this week, attorney and Baylor University alumnus John Eddie Williams, Jr., was honored with a bronze bust placed at the south end zone of Baylor’s McLane Stadium. Williams attended Baylor on a football scholarship as an undergraduate, and has since generously donated to the school’s athletics program. Thanks to his donations, the field at McLane Stadium bears the name John Eddie Williams Field.
After finishing his undergraduate degree, Williams continued his education at Baylor Law School, to which he has also generously donated. At the bust unveiling, Williams stated “Other people’s generosities in the past allowed me to come here and so I always have thought that the right thing for me to do is to give back.”
Wednesday, November 11th, 2015 at 1:56 pm
At Williams Kherkher, we are pleased to announce that Armi Easterby has joined Steve Khereker, John Eddie Williams, Jim Hart, and John Boundas as a partner in our firm. Armi has been the head of our commercial litigation section for some time now, where he will continue to provide guidance and counsel on the environmental cases, intellectual property disputes, and the other commercial litigation matters that our firm handles. For as much as Armi has done for our firm, he has also been very active in the community where he has actively mentored young attorneys entering into the profession. With that being said, please join our team in congratulating Armi on his fine work and this well-deserved recognition.
Tuesday, November 10th, 2015 at 10:46 am
Our team is proud to announce that our very own John Eddie Williams was recently honored with the Joseph D. Jamail Award for Justice that is presented by Aid to Victims of Domestic Abuse (AVDA), a Houston-based non-profit. This award honors “‘unparalleled community service and advocacy for those who cannot afford legal representation’” and reflects the extensive pro bono work that Williams has donated to this valuable organization. Founded in 1980, AVDA provides direct support and advocacy to families that have been victimized by domestic abuse.
Over the years, Williams and his wife, Sheridan, have distinguished themselves as philanthropists in Houston. The couple has helped to fund research in Houston hospitals, donated toys to underprivileged families, and have directly supported many other causes like AVDA.
Monday, November 9th, 2015 at 8:25 am
Leiomyosarcoma is a type of cancer that forms from smooth muscle cells in the soft tissues, usually in the gastrointestinal tract or the uterus. When these cells develop in the muscular part of the uterus, it is referred to as uterine leiomyosarcoma. This type of cancer is most common in women who range in age from 40 to 60.
One thing that has been identified as a danger to women who are at risk of developing this cancer is the power morcellator. This tool uses a rotating blade to break up large portions of fibroid tissues into smaller fragments and then vacuum them away from the body. When morcellators are used on fibroids that contain cancer cells, the act of breaking them up can release those cells and allow them to scatter throughout the body. This often leads malignant cells to grow much more rapidly than they would have otherwise, expediting the growth of metastatic leiomyosarcoma in the body.
If you were diagnosed with uterine or metastatic leiomyosarcoma after a procedure involving a power morcellator, please do not hesitate to contact the attorneys at Williams Kherkher. We want to fight for you and your rights so that you can focus on your recovery. Call us now at (800) 220-9341 to learn more.
Friday, November 6th, 2015 at 1:41 pm
Women who have undiagnosed uterine cancer may be at a higher risk of those cells spreading if they undergo medical procedures in which power morcellators are used. These instruments can cause additional harm by releasing concealed cancerous cells in early developmental stages during the process of breaking up fibroids or other growths. By releasing these cancerous cells, morcellators allow them to grow in new and dangerous areas of the body where they would not have otherwise spread so quickly. Morcellators may actually advance cancers from early stages to later stages.
Women are at a particularly high risk of developing uterine cancer as a result of morcellator procedures. A few symptoms to watch for after this type of procedure are:
- Nausea or vomiting
- Swelling of the abdomen or the pelvis
- Pelvic or abdominal pain
- Vaginal discharge
- Vaginal bleeding or spotting, which may occur after menopause or between monthly periods
- Weight loss
Other symptoms include back pain and nerve issues if the tumor affects organs or bones such as the spinal cord.
Friday, November 6th, 2015 at 10:29 am
The Oregon Insurance Division has released a memorandum last Thursday, November 5 regarding the coverage for the dialysis of chronic kidney disease patients.
The division said it plans to address some concerns of dialysis providers and patients related to this procedure regarding how some insurance plans make use of Medicare to cover treatments. The division did not name insurance companies who have been engaging in this questionable practice.
The division also named requirements for health plans concerning end-stage renal disease. Among the most prominent in the list of requirements is the mandate that insurers are not allowed to require enrollment in Medicare to cover for dialysis payments; what they can do is provide members with the information they need to gain access to Medicare benefits.
Our attorneys at Williams Kherkher know how important it is for patients dealing with dialysis to get the financial assistance they need. We also understand that patients have been known to suffer additional cost-incurring issues when the kidney dialysate GranuFlo is administered, as this drug has been known to cause harm to users. If you have suffered at the hands of an unscrupulous manufacturer of defective pharmaceutical products, call our offices at (800)220-9341 today to learn how we can help you pursue justice in the form of compensation.
Saturday, October 31st, 2015 at 12:34 pm
Pharmaceutical companies Johnson & Johnson (J&J) and Bayer are facing lawsuits after a man who had been taking the blood-thinning drug Xarelto suffered a stroke and died.
According to the lawsuit filed by a woman in a Philadelphia court, her father died of stroke after taking Xarelto for four days. The woman, whose name was withheld, claimed that the anticoagulant drug was wrongfully advertised. Reports said the allegation against Xarelto for failing to prevent strokes in patients with irregular heartbeat patterns is the first of its kind.
While the USFDA approved Xarelto for the reduction of stroke risks in patients in 2011, an agency reviewer contradicted to the approval, claiming that this prescription actually put patients’ lives at risk. The lawsuits against Xarelto continue to grow as people claim that the bleeding side effect of the drug is irreversible.
The lawyers of Williams Kherkher advocate for families and their loved ones who believe that they suffer from effects caused by Xarelto. If you have taken this drug recently or in the past, call us at (800) 220-9341 today to learn more about the services we offer and how we may be able to help you.
1 2 3 … 49 Next »